Explore
For Enterprise
Join for Free
Log In

艺术与人文
商务
计算机科学
数据科学
信息技术
健康
数学和逻辑
个人发展
物理科学与工程
社会科学
语言学习
学位
证书

浏览 Coursera 的全部课程

浏览
搜索
企业版
登录
免费加入

Determining an Innovation Strategy

Loading...

企业成长战略

弗吉尼亚大学

4.7（356 个评分） | 16K 名学生已注册

课程 3（共 5 门，商业战略专项课程）

Get the tools you need to analyze, evaluate and recommend specific actions organizations can take to grow their value and avoid common growth pitfalls. Learn to determine how best to build value, whether by scaling existing markets, entering established markets or creating new markets through innovation and acquisitions. Apply these concepts in case studies of industry leaders JetBlue, Starbucks, Intel Corporate Venturing and Tata Motors.

查看授课大纲

您将学习的技能

Mergers And Acquisitions (M&A), innovation strategy, Strategic Thinking, Business Strategy, growth strategy

审阅

4.7（356 个评分）

5 stars
276 ratings
4 stars
68 ratings
3 stars
9 ratings
2 stars
1 ratings
1 star
2 ratings

FM

Dec 13, 2017

As part of my path towards analyzing business in whose stock to invest, this course is a perfect addition to my tool belt.

SR

Sep 22, 2016

Very good followup course .. Doing this course provides an order and clarity to the thought process towards growth

从本节课中

Growth through Innovation

Introducing new ideas, processes, and products that disrupt the market is another common growth strategy. In this module, we'll unlock the keys to innovation, from building an innovative capability to appropriating value from innovation to determining an innovation strategy. Using the Real Options Analysis tool, we'll show you how to grow through innovation and good practices for doing so. The Intel Corporate Venturing case provides an opportunity for you to practice this tool and apply course concepts to a real-world scenario.

Growing through Innovation7:15

Innovation Strategies3:26

Developing an Innovative Capability6:49

Keys to Innovation3:55

Organizing for Innovation6:47

Appropriating Value from Innovations2:01

Intellectual Property Protection7:08

Complementary Assets4:07

Determining an Innovation Strategy5:21

Module Lessons1:27

教学方

Michael Lenox
Senior Associate Dean and Chief Strategy Officer
Jared Harris
Samuel L. Slover Research Chair in Business Administration

脚本

So we've talked about the importance of IP protection.

We've talked about the importance of complementary assets, so

let's ask the question of who profits for innovation in various scenarios here.

So here we have a little two by two.

We talk about weak versus strong intellectual property protection, and

we talk about complementary assets that are either widely available or generic, or

tightly held and specialized.

So take the scenario in the bottom left corner.

We have strong IP protection and

we have complimentary assets that are widely available or generic.

This is gonna advantage the innovator.

The innovator has strong IP protection and

they're able to access the complimentary assets that they need.

On the opposite diagonal, we have a situation where there's weak

IP protection and there's a tightly held complementary asset.

Then we would expect the complementary asset holder to prevail.

Once again, going to my previous example of Walmart having a dominate distribution

channel and a new innovator needing to use Walmart as a distributor.

Now if we're in a world of where we have weak IP protection and we have widely

available or generic complementary assets, this is actually a world where

it's difficult to make money just simply because we have a competitive market.

We're think we'll probably likely have competition both

on the innovation side and on the complimentary asset side.

On the other diagonal where we kinda have a strong strong situation, well then it

really comes down to bargaining power between those with IP protection and

those with complimentary assets.

So who has bargaining power?

Well once again we wanna think about the relative dependence of the innovation

on the asset and

then think of that as a ratio of the dependants of the asset on the innovation.

So the higher that ratio the more dependent the innovation is on the asset.

On the other diagonal here, excuse me, other dimension here,

we had the degree to which the asset is tightly held by the non-innovator again,

that I don't have any other option when trying to bring my innovation to market.

Well again, well those are low,

we're in a world where the innovator has the bargaining power.

When those are high both dimension, the asset holder has bargaining power.

And everything else becomes kind of shades of gray between these two extremes when it

comes to bargaining power here.

So, what did you do if you're an innovator and you lack a tightly held asset?

Well, if you go back to our two by two here, again

if you have strong intellectual property protection the assets widely available,

just simply use the market here.

You've got an advantage, you can go ahead and bring that product and

service to market.

Again, if we're in the weak generic quadrant,

well they're really are no good options here cuz we have a competitive market.

And it's gonna be very hard to appropriate value in that case.

If you're in the weak position as the innovator and there is this tightly held

or specialized asset, well then you might wanna consider integration.

You might wanna consider either being acquired or acquiring the asset provider.

And if we're in the strength situation,

the bargaining situation we talked about before,

it's important to recognize that we have the possibility of integrating together,

but we also might have a strategy for example of licensing technology.

So where you see this quite often is in the pharmaceutical industry where we have

these biotech companies, usually smaller entrepreneurial concerns,

who are coming out with new drug discoveries.

They lack the infrastructure for the sales, and marketing and

distribution of their drugs, which the pharmaceutical companies have.

But they do have strong IP protection in the form of patents.

As a result, there's a very robust market for licensing drugs and their patents

from the biotech companies to the pharmaceutical companies in those worlds.

So to summarize here, think about the following decision tree for innovation.

A series of questions you can ask yourself, and

then perhaps the recommended strategy for each of those.

So first we just simply wanna ask, is innovation important to our industry?

If the answer's no, then let's not worry to much about innovation.

I think we could argue in this day and

age that's a very rare occurrence where we're going to not worry about innovation.

So if we're worried about it we're in the yes column here,

ask yourself first do we have an innovative capability?

If the answer's no, then you might wanna think about a second mover strategy,

a fast follower strategy.

Maybe you acquire technology, maybe you imitate others.

Maybe you form partnerships and

collaborate in order to generate innovation.

But if the answer's yes and

you think you have a capability here and you can come up with some new ideas,

then you wanna ask the question about this intellectual property regime.

If it answer is it's not tight and it's hard to predict, then you might actually

wanna think about well maybe we should be doing an imitate strategy, or

second mover strategy.

But if you do think you can appropriate some of the value because the IP regime is

tight, then you gotta ask about the complimentary assets.

If you own and control those complimentary assets, or that they're not tight,

or not important, well then you go ahead an commercialize it yourself.

However, if there are some constraints here,

some bottlenecks you need to be concerned about, then you need to ask,

how widely available are these complimentary assets.

If they're not, think about licensing or contracts.

If they are, then once again you might commercialize, or use the market yourself.

So again I wouldn't suggest this is a hard and fast set of rules,

but it's at least a way to start thinking through these sets of questions about

appropriability and the ability to innovate.

探索我们的目录

免费加入并获得个性化推荐、更新和优惠。

Coursera 致力于普及全世界最好的教育，它与全球一流大学和机构合作提供在线课程。

© 2019 Coursera Inc. 保留所有权利。

通过 App Store 下载

通过 Google Play 获取

Coursera
关于
管理团队
工作机会
目录
证书
MasterTrack™ 证书
学位
企业版
政府版

社区
Learners
Partners
Developers
Beta Testers
Translators

连接
博客
Facebook
领英
Twitter
Instagram
YouTube
技术博客

更多
条款
隐私
帮助
内容访问
媒体
联系我们
目录
附属公司